We are joined onsite by Dr Mathieu Kerneis (Pitie Salpetriere APHP University Hospital, FR) and Dr Gilles Montalescot to discuss the findings from the ARAMIS trial.
ARAMIS was the largest randomised controlled trial of acute myocarditis. The study included 120 hospitalised, symptomatic patients with increased cardiac troponin and diagnosed acute myocarditis using cardiac magnetic resonance imaging. They were randomly allocated 1:1 to recieve either a daily subcutaneous dose of anakinra 100mg, or placebo until their discharge from hospital.
Results showed that anakinra was safe, but did not reduce the complications of acute myocarditis.
Recorded on-site at ESC Congress 2023, Amsterdam.
Visit Radcliffe Cardiology: www.radcliffecardiology.com/?...
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on Twitter: / radcliffecardio
27 авг 2023
